The United States Patent and Trademark Office (USPTO) has issued a design patent, USD1120323S1, for a novel medical instrument designed for eye surgical procedures. The patent, filed on January 17, 2025, and granted with an effective date of March 24, 2026, is assigned to OERTLI-INSTRUMENTE AG. This grant signifies the USPTO's recognition of the unique design of the instrument.

This patent grant is primarily an intellectual property matter and does not impose new regulatory obligations or compliance requirements on medical device manufacturers. However, it confirms exclusive rights for the assignee regarding the design of this specific surgical instrument, potentially impacting market entry or licensing for competitors in the ophthalmic surgical device sector.